Erasca Insider Sells $671K as Stock Jumps 189% This Past Year

This oncology biotech developing targeted cancer therapies saw a key insider significantly trim their direct equity stake.Garner Ebun, general counsel and corporate secretary of Erasca (ERAS +9.71%), executed an options exercise and immediate sale of 120,000 shares for a total value of $670,812 on Jan. 7, as disclosed in a recent SEC Form 4 filing.Transaction summaryMetricValueShares sold (direct)120,000Transaction value$670,800Post-transaction shares (direct common stock)25,076Post-transaction value (direc ...